Search Clinical Trials

589,087 trials

NCT07643974
Not Yet RecruitingEarly Phase 1
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTDMedstar Health Research Institute
NCT07645196
Not Yet RecruitingNot Applicable
Effects of Physiotherapy on Ultrasound and Clinical Parameters in Women With DysmenorrheaVrije Universiteit Brussel
NCT07645391
Recruiting
Targeted Early Detection Program in Men at High Genetic Risk for Prostate CancerNational Cancer Institute (NCI)
NCT07645664
Not Yet RecruitingNot Applicable
Scar Management Through Serial CastingCentre hospitalier de l'Université de Montréal (CHUM)
NCT07646080
Not Yet RecruitingPhase 2
Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma ProtuberansYanjie Zhang, MD
NCT07644962
Not Yet Recruiting
Research Project on the Interaction Between Immune Function and Infectious Diseases in Older Adults and the Development of Prevention and Control StrategiesHuashan Hospital
NCT07646262
RecruitingNot Applicable
Gluten-Free vs Mediterranean Diet in Rheumatoid ArthritisHasan Kalyoncu University
NCT07644221
Not Yet RecruitingNot Applicable
Feasibility and Effects of Noninvasive Brain Stimulation on Pain Perception in People With FibromyalgiaDepartment of Anesthesiology & Perioperative Medicine, University of Pittsburgh
NCT07645950
Not Yet Recruiting
Effect of the MIROKI Companion Robot on Anxiety in Pediatric RadiotherapyInstitut du Cancer de Montpellier - Val d'Aurelle
NCT07644754
Not Yet RecruitingNot Applicable
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesLudwig-Maximilians - University of Munich
NCT07646171
Recruiting
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)Tel-Aviv Sourasky Medical Center
NCT07646509
RecruitingNot Applicable
An Ecological Momentary Intervention for the Reduction of Impairment in Somatic Symptom DisorderUniversity of Vienna
NCT07646028
Not Yet RecruitingPhase 1
R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS)Rise Therapeutics LLC
NCT07644130
Not Yet RecruitingNot Applicable
Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive DisorderTampere University
NCT07646249
Not Yet Recruiting
VENtilation Modalities During Transport of PostoperatIve CRITically Ill Patients to the ICUAzienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
NCT07645248
Not Yet RecruitingPhase 3
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)GlaxoSmithKline
NCT07644897
RecruitingPhase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen University
NCT07643844
Not Yet RecruitingPhase 1
AAVrh10-PCCA Gene Therapy for Propionic AcidemiaMayo Clinic
NCT07645521
CompletedNot Applicable
Trans-nasal Sphenopalatine Ganglion Block for Prevention of Emergence Agitation Following Functional Endoscopic Sinus SurgeryMansoura University
NCT07643922
Not Yet RecruitingNot Applicable
Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid HemorrhageBeijing Tiantan Hospital